The claudin gene family: expression in normal and neoplastic tissues

BackgroundThe claudin (CLDN) genes encode a family of proteins important in tight junction formation and function. Recently, it has become apparent that CLDN gene expression is frequently altered in several human cancers. However, the exact patterns of CLDN expression in various cancers is unknown, as only a limited number of CLDN genes have been investigated in a few tumors.MethodsWe identified all the human CLDN genes from Genbank and we used the large public SAGE database to ascertain the gene expression of all 21 CLDN in 266 normal and neoplastic tissues. Using real-time RT-PCR, we also surveyed a subset of 13 CLDN genes in 24 normal and 24 neoplastic tissues.ResultsWe show that claudins represent a family of highly related proteins, with claudin-16, and -23 being the most different from the others. From in silico analysis and RT-PCR data, we find that most claudin genes appear decreased in cancer, while CLDN3, CLDN4, and CLDN7 are elevated in several malignancies such as those originating from the pancreas, bladder, thyroid, fallopian tubes, ovary, stomach, colon, breast, uterus, and the prostate. Interestingly, CLDN5 is highly expressed in vascular endothelial cells, providing a possible target for antiangiogenic therapy. CLDN18 might represent a biomarker for gastric cancer.ConclusionOur study confirms previously known CLDN gene expression patterns and identifies new ones, which may have applications in the detection, prognosis and therapy of several human cancers. In particular we identify several malignancies that express CLDN3 and CLDN4. These cancers may represent ideal candidates for a novel therapy being developed based on CPE, a toxin that specifically binds claudin-3 and claudin-4.

[1]  G. Riggins,et al.  Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. , 2000, Cancer research.

[2]  O. Cummings,et al.  Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. , 2001, Cancer research.

[3]  Xin Chen,et al.  Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  P. Morin,et al.  Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. , 2005, Cancer research.

[5]  M. Kubbies,et al.  Role of claudins in tumorigenesis. , 2005, Advanced drug delivery reviews.

[6]  S. Tsukita,et al.  Pores in the Wall , 2000, The Journal of cell biology.

[7]  Takeshi Iwamura,et al.  Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. , 2003, Cancer research.

[8]  E. Siegel,et al.  Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin. , 2005, Cancer research.

[9]  P. Argani,et al.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast , 2003, Oncogene.

[10]  Christine A Iacobuzio-Donahue,et al.  Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. , 2004, American journal of clinical pathology.

[11]  Kenneth H Buetow,et al.  An anatomy of normal and malignant gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Smahi,et al.  Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. , 2004, Gastroenterology.

[13]  Kathleen R. Cho,et al.  Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  D R Schwartz,et al.  Coordinately up-regulated genes in ovarian cancer. , 2001, Cancer research.

[15]  S. Altschul,et al.  A public database for gene expression in human cancers. , 1999, Cancer research.

[16]  Raheela Ashfaq,et al.  Claudin 4 Protein Expression in Primary and Metastatic Pancreatic Cancer , 2004 .

[17]  S. Riazuddin,et al.  Mutations in the Gene Encoding Tight Junction Claudin-14 Cause Autosomal Recessive Deafness DFNB29 , 2001, Cell.

[18]  M. Löhr,et al.  Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. , 2001, Gastroenterology.

[19]  J. Katahira,et al.  Clostridium perfringens Enterotoxin Utilizes Two Structurally Related Membrane Proteins as Functional Receptors in Vivo * , 1997, The Journal of Biological Chemistry.

[20]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[21]  R. Lifton,et al.  Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. , 1999, Science.

[22]  R. Folz,et al.  Poly(A) cDNA-specific (PACS) RT-PCR: a quantitative method for the measurement of any poly(A)-containing mRNA not affected by contaminating genomic DNA. , 2000, BioTechniques.

[23]  Pedram Argani,et al.  Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. , 2004, The American journal of pathology.

[24]  Y. Mitani,et al.  Down‐regulation of the claudin‐18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype , 2006, The Journal of pathology.

[25]  Geoffrey J. Barton,et al.  The Jalview Java alignment editor , 2004, Bioinform..

[26]  P. Morin,et al.  Claudin proteins in human cancer: promising new targets for diagnosis and therapy. , 2005, Cancer research.

[27]  E. Sabo,et al.  Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study , 2005, Modern Pathology.

[28]  C. Moskaluk,et al.  Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. , 2005, The American journal of pathology.